A disease of cortisol is a disease with a psychological surface.
Modern treatment keeps people biochemically adequate but frequently leaves them not feeling well. This dossier brings together the full body of work — a health-psychology literature landscape, an evidence map across every research angle, two comparator analyses, and the MRes project framing that sits on top of it.
The central argument
Care keeps people biochemically adequate but frequently leaves them not feeling well — persistent fatigue, low mood, cognitive fog and impaired quality of life. The leading hypothesis is that tablets replace the hormone but not its rhythm, and that this residual burden is fundamentally a health-psychology problem.
Crisis prevention — the difference between living and dying with this condition — is a behaviour-change problem, and psychological stress is a direct physiological trigger of crisis. Few conditions map onto health psychology so cleanly.
Where the white space is
- wide open Illness perceptions, coping & adjustment
- open The intention–action gap in crisis self-management
- wide open Psychometric depth of AddiQoL (invariance / DIF)
- hinted Subjective vs objective cognition divergence
- emerging Stress as a crisis mechanism
Assessing the impact of adrenal insufficiency on health & wellbeing in adults on the Island of Ireland.
A health-psychology and nutrition study that asks a deceptively simple question: if patients on the same treatment report wildly different experiences, are there distinct subtypes hiding inside the "one-size-fits-all" model — and could profiling them point toward tailored, real-world management between clinic appointments?
The gap this fills
Even with lifelong steroid replacement, patients consistently report poor quality of life, higher depression and anxiety, cognitive difficulty and significant fatigue — and the management approach hasn't meaningfully changed in over sixty years. Around 40% will experience at least one life-threatening adrenal crisis.
What stands out from the literature is how individual the experience is: different responses to the same medications, stressors and routines. Yet nobody has systematically profiled these patients — nutritionally and psychologically — to test whether distinct subtypes exist that might respond to tailored approaches. That's the gap.
Why it's the right seam
It lands squarely on the landscape's biggest white space — illness perceptions, coping and adjustment in PAI — while adding a genuinely novel nutritional-profiling dimension that existing health-psychology work doesn't touch.
The approach
| 1 · Psychological profiling | Validated health-psychology instruments — illness perceptions (Brief IPQ), disease-specific quality of life (AddiQoL), coping and self-efficacy — to characterise how patients appraise and manage the condition. |
| 2 · Nutritional profiling | Dietary and biomarker methodology (including vitamin D), drawing on the Nutrition Innovation Centre for Food and Health (NICHE) — a dimension absent from the current PAI psychology literature. |
| 3 · Subtype identification | Bringing the two profiles together to test whether meaningful patient subtypes emerge — the empirical basis for any future tailored intervention. |
| 4 · Toward tailored management | Using the subtypes to frame how real-world, between-appointment self-management could be personalised — the question a funded PhD would carry forward. |
Supervisory team — Ulster University
The researcher
A chemist by training — BSc and MSc at Queen's University Belfast, then 7+ years as a Research Chemist at Almac Sciences in purification and process optimisation under GMP conditions: interpreting complex analytical data, solving problems under pressure, delivering outputs that had to be right first time. That rigour with data transfers directly into health research.
The motivation is not only academic. Lived experience of managing a chronic condition is what draws the work toward patient-centred research — the conviction that the real challenge isn't the diagnosis or the prescription, but everything that happens afterwards: the uncertainty, the self-management, and the gaps where patients are left on their own.
Medical primer
Read once, then move on. Addison's disease (primary adrenal insufficiency, PAI) is destruction of the adrenal cortex — autoimmune in ~80–90% of adult cases in the developed world — so the body stops making cortisol (the stress/circadian glucocorticoid) and usually aldosterone (salt/fluid balance). Onset is typically 30–50, with a female skew.
Primary, secondary & tertiary — one psychological surface, three upstream causes
Primary (Addison's)
The adrenal cortex itself is destroyed — autoimmune in ~80–90% of adult cases. Both cortisol and aldosterone fail and ACTH runs high; mineralocorticoid replacement (fludrocortisone) is needed alongside glucocorticoid. This is the dossier's main anchor.
Secondary & tertiary
The adrenal gland is intact but under-driven — secondary from inadequate pituitary ACTH, tertiary from inadequate hypothalamic CRH (most often after prolonged exogenous steroids). Cortisol is deficient but aldosterone is usually preserved (the renin–angiotensin system is intact), so mineralocorticoid replacement is generally not required — yet adrenal-crisis risk remains.
Four facts that do all the work for the psychology
1 · Treatment replaces the hormone but not the rhythm
2 · That approximation is the likely engine of the psychological burden
3 · Adrenal crisis is the acute, lethal event
4 · Mortality remains elevated despite replacement
The health psychology core
Organised by psychological construct rather than by organ. Relative maturity is flagged on each: developed emerging thin / opportunity
1 · Health-related quality of life & PROMsdeveloped
The most developed strand, and the natural anchor for health-psychology work.
- AddiQoL is the disease-specific HRQoL instrument — developed by Løvås et al. (2010) and validated across five European cohorts by Øksnes et al. (2012). 30-item and 8-item forms, Cronbach's α ≈ 0.93. Women and older patients score worse.
- Foundational subjective-health work (Løvås et al., 2002) found fatigue elevated in both sexes, ~26% work disability (vs ~10% general population), and HRQoL impairment comparable to chronic heart failure — a striking benchmark for a "treated" condition.
- Hahner et al. (2007) confirmed impaired subjective health in 256 patients on standard therapy.
2 · Fatigue and vitalitydeveloped
Fatigue is the single most consistently reported symptom and the one least corrected by "adequate" replacement. It dominates patient-reported symptom lists in every survey, correlates with dosing timing, and overlaps heavily with QoL and mood — making it hard to model as an independent construct. It is the symptom most often cited by patients as the gap between "biochemically fine" and "feeling well."
3 · Affective & psychiatric morbiditydeveloped
- Thomsen et al. (2006) — Danish register; affective-disorder rate elevated ~2.7× overall, ~2.1× in the Addison's subgroup specifically.
- Stewart et al. (2016) — US database; depression OR ~2.4 in PAI; elevated anxiety.
- Harasymiw et al. (2023) — adrenal-insufficiency youth; raised depression/anxiety prevalence and antidepressant use.
4 · Cognition & subjective cognitive complaintsemerging
A real, unresolved tension in the literature:
- One cluster (South African group: Henry, Thomas, Ross) reports episodic/verbal memory impairment, substantially mediated by disrupted sleep.
- Another (Berlin: Schultebraucks et al.; Swedish registry: Van't Westeinde et al., 2022) finds objective cognition largely preserved but subjective executive difficulty and mental fatigue — worse at lower glucocorticoid doses.
- A crossover study found fludrocortisone (raising mineralocorticoid-receptor occupancy) improved verbal memory and mood — a neat mechanistic hint that the type and timing of replacement, not just the amount, shapes cognition.
- The systematic review (Ramos-Leví et al., 2022) found only ~10 eligible articles, 3 directly on cognition — the evidence base is genuinely small.
5 · Illness representations, coping & adjustmentthin
This is where the field is thinnest — and therefore most open. Despite cortisol being the stress hormone, there is very little Addison's-specific work using core health-psychology frameworks: Leventhal's Common-Sense Model (illness perceptions → coping → outcomes), self-efficacy, or adjustment trajectories. Dedicated, validated illness-perception studies in PAI are close to absent. For someone building a health-psychology research programme, this is the clearest white space.
6 · Self-management, adherence & behaviour changeemerging
Crisis prevention is fundamentally a behaviour-change problem, and the literature is starting to treat it that way.
- Education alone is insufficient. Hahner et al. (2015) found crises occurred at ~8.3 per 100 patient-years even in educated patients, with prior crisis the strongest predictor of future crisis. Knowing the rules ≠ executing them under acute stress.
- A 2024 review (Martel-Duguech et al.) stresses that preventive education and parenteral hydrocortisone self-administration must be taught repeatedly — implicitly conceding that one-shot education fails as a behaviour-change mechanism.
- The behavioural sticking points are textbook health psychology: sick-day-rule adherence under illness-related cognitive load, self-efficacy for self-injection (many patients are afraid to inject), and the intention–action gap during the exact physiological state (a crisis) that degrades decision-making.
- A COM-B / Behaviour Change Wheel lens fits almost perfectly and is barely applied: capability (knowledge + injection skill), opportunity (kit, supportive other, emergency card), motivation (fear, fatalism, denial of severity).
7 · Psychological stress as a physiological triggeremerging
Uniquely for this condition, psychological stress is not just an outcome but a direct precipitant of physical crisis — emotional stress accounts for roughly 20% of crisis triggers in prospective data. This creates a bidirectional loop (stress → cortisol demand → crisis risk → anxiety → more stress) that is conceptually rich and almost entirely unstudied as a psychological mechanism. Stress-management and emotion-regulation interventions have an unusually direct physiological rationale here.
8 · Lived experience, identity & qualitative workemerging
The smallest but fastest-growing strand. Recurrent themes (often recruited via patient organisations such as ADSHG and the Pituitary Foundation): self-management learned autodidactically rather than taught; hypervigilance and the cognitive burden of constant risk-monitoring; the "invisible illness" identity problem (looking well while managing a lethal condition); and gaps in professional knowledge that force patients into expert-patient roles. Fertile ground for IPA (interpretative phenomenological analysis) and identity-focused work.
9 · Social, occupational & sexual wellbeingemerging
- Work: elevated disability and absenteeism recur across surveys; occupational health is under-theorised.
- Sexual wellbeing: women show reduced circulating androgens (Erichsen et al., 2010); dysfunction is framed as multifactorial and under-investigated, especially in men and post-menopausal women. The DHEA adjunct literature (modest, inconsistent effects) is the cautionary tale of a once-promising psychological lever that didn't deliver robustly.
- Relationships/caregivers: family and partner burden is mentioned but essentially unstudied.
10 · Digital & behavioural interventionsthin → emerging
Early app-based and Behaviour-Change-Wheel-designed self-management tools are appearing (e.g. structured digital support for sick-day rules and crisis preparedness). Evidence is preliminary. Given the behavioural nature of crisis prevention, this is a plausible growth area — and one where a hyper-personalisation / profiling approach could be genuinely novel.
Theory, trends & gaps
Mapping mainstream health-psychology models onto Addison's shows how little of this has been done — each row is an open research line.
Theoretical scaffolding
| Framework | Natural application to PAI | Status |
|---|---|---|
| Common-Sense Model (Leventhal) | Illness perceptions (timeline, control, consequences) → coping → QoL and adherence | barely applied |
| Social Cognitive Theory (Bandura) | Self-efficacy for sick-day dosing & self-injection as the key mediator of crisis prevention | implicit only |
| COM-B / Behaviour Change Wheel | Diagnosing why educated patients still don't act in a crisis; designing interventions | open |
| Transactional stress–coping (Lazarus & Folkman) | Appraisal of stressors that are literally physiologically dangerous here | open |
| Self-Regulation / symptom perception | Subjective cognitive/fatigue complaints vs objective measures | hinted |
| Psychometric / measurement theory | Invariance, DIF and responsiveness of AddiQoL across demographic subgroups | wide open |
Part IV — Trends
- Reframing from "treated and fine" to "treated with residual psychological burden."
- Rise of patient-reported outcomes as legitimate endpoints (AddiQoL's adoption is the marker).
- Therapeutic interest in restoring the cortisol rhythm (modified-release, infusion) — putting psychological outcomes at the centre of biomedical trials.
- Crisis prevention migrating from "educate harder" to behaviour-change science — slowly.
- Qualitative and lived-experience work emerging from a near-zero base.
Part V — Gaps
- Illness perceptions, coping and adjustment essentially unmapped — the single biggest open seam.
- The intention–action gap in crisis self-management described but not explained with behavioural models.
- Subjective vs objective cognition divergence unresolved and under-theorised.
- Psychological stress as a crisis trigger has a strong physiological rationale but no serious psychological-mechanism literature.
- Psychometric depth is shallow — no published invariance/DIF work on the main PROM.
- Whole populations under-studied: men, older adults, post-menopausal women, caregivers.
- Most psychiatric-prevalence data pools PAI with other adrenal insufficiencies.
Where to take the research
A pragmatic ladder, lightest to most ambitious. The MRes project most naturally lives on the first two or three rungs.
| 1 · An illness-perception study in PAI | Brief IPQ + AddiQoL + a coping measure — low-cost, fills the most obvious gap, and generates a Common-Sense Model for the condition. |
| 2 · A COM-B diagnosis of the crisis self-management failure | Qualitative + survey, mapping capability / opportunity / motivation barriers to self-injection and sick-day dosing; directly intervention-relevant. |
| 3 · A psychometric paper on AddiQoL | Measurement invariance / DIF across sex, age and (if data allow) neurodivergent vs neurotypical respondents; methodologically defensible and under-occupied. |
| 4 · A theory-driven, possibly digital intervention | Self-management / stress-management with a self-efficacy mediator and crisis incidence as a distal outcome. |
Benchmarks that would shift the field
- A validated PAI illness-perception model linked to outcomes.
- A behaviour-change intervention that demonstrably reduces crises — not just knowledge scores.
- PROM invariance evidence that lets subgroup QoL comparisons actually mean something.
Coverage across every angle
The underlying corpus — 161 scholarly records drawn from open scholarly APIs — sorted by research angle. Bar length is record incidence per angle; it shows the shape of attention, not a quality judgement.
What a comparator reveals about where the research went
Addison's disease set against two reference conditions. A comparator exposes the shape of attention — which angles a field has invested in, and which it has left dark.
1 · Addison's vs hypoparathyroidism — coverage by angle
Record counts from the evidence map (Addison's baseline = 161; hypoparathyroidism = 6). Angle incidence, not true literature volume.
2 · Addison's vs ME/CFS — relative research emphasis
A qualitative characterisation of how much each field has invested per angle (0–4 scale), not record counts. ME/CFS is the sharper comparator: its literature is the near-mirror image of Addison's.
Community & lived-experience leads
Patient/community sources are tracked as leads and accessed only via legitimate routes (official Graph / LinkedIn / Reddit APIs, RSS, or owner permission) — logged-in feeds are never scraped.
| Source | Type | Legitimate access / note |
|---|---|---|
| Addison's Disease Self-Help Group (ADSHG) | patient-advocacy | Recruits participants for qualitative self-management research (UK). Public website / published resources; partner for data with permission. |
| AddisonsDisease subreddit | social-community | Lived-experience signal; ingest only via the official Reddit API (OAuth) — not scraping. |
| NICE 2024 Guideline (adrenal insufficiency) | NICE | Identification and management of adrenal insufficiency. |
| Hypoparathyroidism Research and Info (Facebook) | social-community | Relevant via APS-1, where hypoparathyroidism and Addison's co-occur. Meta Graph API (Page Public Content Access) or owner permission — not scraping. |
| NORD — Addison's Disease | advocacy-reference | Authoritative lay/clinical summaries; good for well-being framing. Public reference pages. |
| The Pituitary Foundation | patient-advocacy | Co-recruits adrenal-crisis self-management study cohorts. Public website / published resources. |
| Understanding patients' experiences of Addison's disease (HRA) | NHS Health Research Authority | Study summary. |
Resources from the hypoparathyroidism comparator cohort
- Venepuncture for calcium assays: should we still avoid the tourniquet?measurement-preanalytical · Diagnosis; Medical / clinical
- The Full Picture of Hypoparathyroidism — UK patient-experience reportpatient-experience-report · QoL & well-being; Self-management
- Living with chronic hypoparathyroidism — final report (PDF)shared-resource · Comorbidity (APS-1)
- Standardised European Emergency Card for Hypoparathyroidism (ESE, 18 languages)society-patient-coproduction · Emergency; Self-management
- Gender differences in long-term complications of chronic hypoparathyroidism: a systematic review (2026)systematic-review · Epidemiology; Medical / clinical; QoL